+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2025-2030- Product Image
AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2025-2030- Product Image
Sale

AI Medical Imaging Software for Cardiovascular Disease Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6125578
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Artificial intelligence is reshaping cardiovascular imaging, transforming how healthcare organizations diagnose, manage, and interpret heart disease. By leveraging algorithm-driven insights and improved image analysis, industry leaders can streamline clinical workflows, improve patient outcomes, and address evolving regulatory and operational demands.

Cardiovascular Imaging AI Software Market Snapshot

The cardiovascular imaging AI software market is experiencing significant growth, fueled by technological advancements and increasing demand for more precise, efficient diagnostic solutions. With a focus on machine learning and deep learning, this market integrates sophisticated analytics into daily workflows, supporting clinicians in the detection and management of complex cardiovascular conditions. A supportive reimbursement landscape, evolving regulatory frameworks, and global investment in healthcare digitization are collectively driving rapid adoption across established healthcare systems and emerging markets.

Scope & Segmentation

  • Applications: Arrhythmia, Congenital Heart Disease, Coronary Artery Disease, Heart Failure, Valvular Disease
  • Technologies: Computer Vision, Deep Learning (Convolutional Neural Network, Generative Adversarial Network, Recurrent Neural Network), Machine Learning (Decision Tree, Random Forest, Support Vector Machine), Natural Language Processing
  • Imaging Modalities: CT (CT Angiography, CT Perfusion), Echocardiography (2D Echo, 3D Echo, Doppler Echo), Fluoroscopy, MRI (Cardiac MRI, MR Angiography), X-Ray
  • End Users: Ambulatory Clinics, Diagnostic Centers, Hospitals, Research Institutes
  • Deployment Modes: Cloud (Hybrid Cloud, Private Cloud, Public Cloud), On Premise (Appliance Based, Server Based)
  • Pricing Models: License, Pay Per Use, Subscription
  • Analysis Types: Automated Quantification, Disease Detection, Image Reconstruction, Risk Prediction
  • Regions: Americas (United States—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—plus Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with major countries such as United Kingdom, Germany, France, Russia, and others), Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, HeartFlow, Inc., Aidoc Medical Ltd., Viz.ai, Inc., Arterys, Inc., Zebra Medical Vision Ltd., Ultromics Ltd.

Key Takeaways

  • Artificial intelligence is enhancing cardiovascular imaging accuracy and efficiency, enabling rapid interpretation and quantification of complex structures.
  • Increasing regulatory support is streamlining the safe introduction of AI-enabled solutions, fostering innovation and compliance throughout the product lifecycle.
  • Integration with electronic health record systems and imaging platforms supports collaborative diagnostics, improving workflow productivity and reducing interobserver variability.
  • Regional adoption patterns reflect diverse healthcare priorities: robust infrastructure and validation partnerships drive uptake in the Americas, while Europe, Middle East, Africa, and Asia-Pacific each emphasize tailored deployment and compliance approaches.
  • Companies are differentiating through real-world evidence generation, alliances with research centers, and expansion into predictive analytics and multi-modal data integration.

Tariff Impact on Cardiovascular Imaging AI Software

New United States tariffs set for 2025 will affect hardware and software supply chains, influencing vendor sourcing, development investments, and procurement costs. Vendors may renegotiate contracts, explore domestic and regional innovation hubs, and emphasize product value to maintain competitiveness. Healthcare providers are likely to select software with well-documented operational and clinical benefits to maximize return on investment under shifting cost pressures.

Methodology & Data Sources

This analysis is based on comprehensive secondary research, including scientific publications, regulatory documents, and company announcements. Primary data was collected through interviews with key opinion leaders, cardiology and radiology specialists, and software executives, supplemented by structured surveys of hospital IT professionals. Triangulation of diverse data points ensures high validity and up-to-date insights.

Why This Report Matters

  • Enables executives to benchmark technology adoption, clinical validation, and regional growth strategies across leading markets and competitors.
  • Supports informed investment, partnership, and procurement decisions by providing actionable intelligence on segmentation, pricing, and deployment preferences.
  • Equips senior decision-makers with verified analysis of tariff implications, regulatory trends, and evolving market drivers.

Conclusion

AI is transforming cardiovascular imaging by facilitating faster, more precise diagnostics and optimized workflows. Leaders can leverage these insights to fuel sustainable growth, anticipate regulatory and economic changes, and strengthen competitive positioning in evolving global markets.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of deep learning algorithms for automated plaque characterization and quantification in coronary CT angiography
5.2. Adoption of edge computing-enabled AI models for real-time cardiac ultrasound analysis at point of care
5.3. Emergence of multimodal imaging AI platforms combining MRI, CT, and echocardiography data for comprehensive cardiac risk stratification
5.4. Implementation of AI-driven workflow optimization tools to reduce cardiovascular imaging report turnaround times
5.5. Development of federated learning frameworks to train robust cardiovascular imaging AI across multiple healthcare institutions
5.6. Regulatory approval and reimbursement pathways shaping commercial deployment of AI-based cardiac imaging software
5.7. Partnerships between AI developers and medical device manufacturers to create interoperable cardiovascular imaging solutions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. AI Medical Imaging Software for Cardiovascular Disease Market, by Application
8.1. Introduction
8.2. Arrhythmia
8.3. Congenital Heart Disease
8.4. Coronary Artery Disease
8.5. Heart Failure
8.6. Valvular Disease
9. AI Medical Imaging Software for Cardiovascular Disease Market, by Technology
9.1. Introduction
9.2. Computer Vision
9.3. Deep Learning
9.3.1. Convolutional Neural Network
9.3.2. Generative Adversarial Network
9.3.3. Recurrent Neural Network
9.4. Machine Learning
9.4.1. Decision Tree
9.4.2. Random Forest
9.4.3. Support Vector Machine
9.5. Natural Language Processing
10. AI Medical Imaging Software for Cardiovascular Disease Market, by Imaging Modality
10.1. Introduction
10.2. CT
10.2.1. CT Angiography
10.2.2. CT Perfusion
10.3. Echocardiography
10.3.1. 2D Echo
10.3.2. 3D Echo
10.3.3. Doppler Echo
10.4. Fluoroscopy
10.5. MRI
10.5.1. Cardiac MRI
10.5.2. MR Angiography
10.6. X Ray
11. AI Medical Imaging Software for Cardiovascular Disease Market, by End User
11.1. Introduction
11.2. Ambulatory Clinics
11.3. Diagnostic Centers
11.4. Hospitals
11.5. Research Institutes
12. AI Medical Imaging Software for Cardiovascular Disease Market, by Deployment Mode
12.1. Introduction
12.2. Cloud
12.2.1. Hybrid Cloud
12.2.2. Private Cloud
12.2.3. Public Cloud
12.3. On Premise
12.3.1. Appliance Based
12.3.2. Server Based
13. AI Medical Imaging Software for Cardiovascular Disease Market, by Pricing Model
13.1. Introduction
13.2. License
13.3. Pay Per Use
13.4. Subscription
14. AI Medical Imaging Software for Cardiovascular Disease Market, by Analysis Type
14.1. Introduction
14.2. Automated Quantification
14.3. Disease Detection
14.4. Image Reconstruction
14.5. Risk Prediction
15. Americas AI Medical Imaging Software for Cardiovascular Disease Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. GE HealthCare Technologies Inc.
18.3.2. Siemens Healthineers AG
18.3.3. Koninklijke Philips N.V.
18.3.4. Canon Medical Systems Corporation
18.3.5. HeartFlow, Inc.
18.3.6. Aidoc Medical Ltd.
18.3.7. Viz.ai, Inc.
18.3.8. Arterys, Inc.
18.3.9. Zebra Medical Vision Ltd.
18.3.10. Ultromics Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET: RESEARCHAI
FIGURE 30. AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET: RESEARCHSTATISTICS
FIGURE 31. AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET: RESEARCHCONTACTS
FIGURE 32. AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONGENITAL HEART DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONGENITAL HEART DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY VALVULAR DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY VALVULAR DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COMPUTER VISION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RECURRENT NEURAL NETWORK, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DECISION TREE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DECISION TREE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RANDOM FOREST, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RANDOM FOREST, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUPPORT VECTOR MACHINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUPPORT VECTOR MACHINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT ANGIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT PERFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT PERFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 2D ECHO, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 2D ECHO, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 3D ECHO, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY 3D ECHO, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DOPPLER ECHO, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DOPPLER ECHO, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CARDIAC MRI, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CARDIAC MRI, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MR ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MR ANGIOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY X RAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY X RAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLIANCE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLIANCE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SERVER BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SERVER BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY LICENSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY LICENSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PAY PER USE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PAY PER USE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY SUBSCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY AUTOMATED QUANTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY AUTOMATED QUANTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DISEASE DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DISEASE DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGE RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGE RECONSTRUCTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RISK PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY RISK PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 187. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 192. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 193. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 194. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 195. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 196. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 197. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
TABLE 198. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2025-2030 (USD MILLION)
TABLE 199. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 200. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 201. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 202. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 203. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 206. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 207. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 208. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 209. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 210. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 211. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 212. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 213. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2018-2024 (USD MILLION)
TABLE 214. CANADA AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2025-2030 (USD MILLION)
TABLE 215. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 220. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 221. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 222. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (USD MILLION)
TABLE 223. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2018-2024 (USD MILLION)
TABLE 224. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY IMAGING MODALITY, 2025-2030 (USD MILLION)
TABLE 225. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2018-2024 (USD MILLION)
TABLE 226. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CT, 2025-2030 (USD MILLION)
TABLE 227. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2018-2024 (USD MILLION)
TABLE 228. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ECHOCARDIOGRAPHY, 2025-2030 (USD MILLION)
TABLE 229. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2018-2024 (USD MILLION)
TABLE 230. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MRI, 2025-2030 (USD MILLION)
TABLE 231. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2024 (USD MILLION)
TABLE 234. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEPLOYMENT MODE, 2025-2030 (USD MILLION)
TABLE 235. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 236. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 237. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ON PREMISE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2018-2024 (USD MILLION)
TABLE 240. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY PRICING MODEL, 2025-2030 (USD MILLION)
TABLE 241. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2018-2024 (USD MILLION)
TABLE 242. MEXICO AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY ANALYSIS TYPE, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY DEEP LEARNING, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL AI MEDICAL IMAGING SOFTWARE FOR CARDIOVASCULAR DISEASE MARKET SIZE, BY MACHINE LEARNING, 2025-2030 (US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this AI Medical Imaging Software for Cardiovascular Disease market report include:
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • HeartFlow, Inc.
  • Aidoc Medical Ltd.
  • Viz.ai, Inc.
  • Arterys, Inc.
  • Zebra Medical Vision Ltd.
  • Ultromics Ltd.

Related Topics

Related Reports

Medical X-Ray Equipment And Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Medical X-Ray Equipment And Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 127 Pages
  • Global
From
AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2025-2030 - Product Image

AI Medical Imaging Software for Cerebrovascular Diseases Market - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
AI Medical Imaging Software for Chronic Cerebrovascular Diseases Market - Global Forecast 2025-2030 - Product Image

AI Medical Imaging Software for Chronic Cerebrovascular Diseases Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Cardiac Imaging Software Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032 - Product Image

Cardiac Imaging Software Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2032

  • Report
  • 255 Pages
  • Global
From
Medical Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Medical Imaging Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.